衛飛雪

博士，校聘教授，博士生導師

太原是新建南路56號c7c7.app公共衛生學院

山西，中國，030001

E-mail：feixuewei@outlook.com; weifeixue@sxmu.edu.cn

個人科研情況的總體描述

主要從事傳染病和腫瘤流行病學研究，以人乳頭瘤病毒（HPV）和宮頸癌為主要研究方向，開展中國男女性HPV感染隊列研究、全球宮頸癌歸因于HPV的危險性研究、全球肛門HPV感染匯總分析等研究，闡明不同人群HPV感染及自然史等重要科學問題。主持國家自然科學基金青年項目和國家科技重大專項青年項目。共發表SCI論文22篇，其中以第一作者在Lancet、Lancet HIV、Clinical Infectious Diseases、Emerging Infectious Diseases、International Journal of Cancer等醫學期刊上發表SCI論文11篇。

教育經歷

2008.09–2013.06.c7c7.app，醫學學士，預防醫學

2013.09–2019.06廈門大學，碩博連讀，流行病學

研究工作經歷

2019.07–2019.10世界衛生組織（WHO，瑞士日內瓦），實習生

2019.11–2023.06國際癌癥研究中心（IARC/WHO，法國里昂），博士后

2023.07至今 c7c7.app/公共衛生學院，教師

學術任職

China CDC Weekly青年編委

研究方向

傳染病流行病學和腫瘤流行病學

近期代表性論著

1)Wei F,Georgos D, Man I, et al. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature.The Lancet.2024, 404: 435-444.

2)Wei F,Gaisa MM, D’Souza G, et al. Epidemiology of anal human papillomavirus infection andhigh-grade lesions in 29,900 men, according to HIV status, sexuality, and age: a collaborativepooled analysisof64 studies.TheLancetHIV. 2021,8:e531-e543.

3)WeiF,GoodmanMT,XiaN,etal.Incidenceandclearanceofanalhumanpapillomavirusinfectionin 16,600 individuals, according to HIV status, gender, and male sexuality: a collaborative pooledanalysisof34longitudinalstudies.ClinInfect Dis.2023.

4)Wei F,Alberts, CJ, Albuquerque, A., & Clifford, GM. Impact of human papillomavirus vaccine against anal human papillomavirus infection, anal intraepithelial neoplasia, and recurrence of anal intraepithelial neoplasia: a systematic review and meta-analysis.J Infect Dis.2023.

5)Wei F, Guo M, Wu T, et al. Sex differences in the incidence and clearance of anogenital humanpapillomavirusinfectioninLiuzhou, China: anobservationalcohortstudy.ClinInfectDis.2020;70(1):82-89.

6)WeiF,SuY,CuiX,etal.Sequentialacquisitionofhumanpapillomavirusinfectionatgenitaland analsites,Liuzhou,China.EmergInfectDis.2020,26(10):2387-2393.

7)WeiF,ShengW,WuX,etal.IncidenceofanogenitalwartsinLiuzhou,southChina:acomparisonofdatafromaprospectivestudyandfromthenationalsurveillancesystem.EmergMicrobesInfect.2017;6(12):e113.

8)WeiF,YinK,WuX,etal.Humanpapillomavirusprevalenceandassociatedfactorsinwomenand men insouth China: a population-basedstudy.EmergMicrobes Infect. 2016, 5(11): e119.

9)Wei F,Xia N, Ocampo R, et al. Age-specific prevalence of anal and cervical HPV infection andhigh-gradelesionsin11,177womenbyHIVstatus:acollaborativepooledanalysisof26studies.JInfectDis.2022.

10)Wei F, Su Y, Yao X, et al. Sex differences in the incidence and clearance of anal humanpapillomavirusinfectionamongheterosexualmenandwomeninLiuzhou,China:Anobservationalcohort study.Int J Cancer. 2019; 145(3):807-816.

11)WeiF,LiM,WuX,etal.Theprevalenceandconcordanceofhumanpapillomavirusinfectionin differentanogenitalsitesamongmenandwomeninLiuzhou,China:Apopulation-basedstudy.IntJCancer.2018;142(6):1244-1251.

12)Lin C, Slama J, Gonzalez P, Goodman M, Xia N, Kreimer A, Wu T, Hessol N, Shvetsov Y, OrtizA, Grinsztejn B, Moscicki A, Heard I, Losa M, Kojic E, Loeff M,Wei F, et al. Cervical screeningresults and anal cancer risk: a collaborative pooled analysis of cervical determinants of anal HPVinfection and highgrade lesions in 13 427 women, according to HIV status.Lancet Infect Dis.2019;19(8):880-891.

13)Huang Y, Wnag H, Li T, Tang J, Yu H, Guo X, Song Q,Wei F, et al. Comparison of differentdetectionstrategiesforscreeningandconfirmingcongenitalcytomegalovirusinfectioninnewbornsinpopulationwithhighseroprevalence:amother-childcohortstudy.TheLancetRegionalHealth-WesternPacific.2021,12.